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Abstract
Background: The genome stability of attenuated live BCG vaccine preventing the acute 
forms of childhood tuberculosis is an important aspect of vaccine production. The pur-
pose of our study was a whole genome comparative analysis of BCG sub-strains and 
identification of potential triggers of sub-strains’ transition.
Results: Genomes of three BCG Russia seed lots (1963, 1982, 2006 years) have been 
sequenced, and the stability of vaccine sub-strain genomes has been confirmed. A com-
parative genome analysis of nine Mycobacterium bovis BCG and three M. bovis strains 
revealed their specific genome features associated with prophage profiles. A number of 
prophage-coded homologs to Caudovirales ORFs were common to all BCG genomes. 
Prophage profiles of BCG Tice and BCG Montreal genomes were unique and coded 
homologs to herpes viruses ORFs. The data of phylogenetic analysis of BCG sub-strain 
groups based on whole genome sequences and genome restriction maps were in con-
gruence with prophage profiles. The only fragmentary similarity of specific prophage 
sequences of BCG Tice, BCG Montreal, and BCG Russia 368 in pair-wise alignments 
was observed, suggesting the impact of prophages on mosaic structure of genomes.
Conclusions: The whole genome sequencing approach is essential for genomes with 
mosaic structure, harboring numerous prophage sequences. Tools for prophage search 
are effective instruments in this analysis.
Keywords: BCG sub-strains, Mycobacterium bovis, genome stability, genome 
rearrangements, prophages
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1. Introduction
Tuberculosis (TB) is one of the top causes of death in the world. Currently, the only autho-
rized vaccine for primary vaccination of children from TB remains BCG, first applied in 
1921. It is broadly used in different countries as part of the national childhood immuni-
zation program. Despite the attempts of TB control through widespread introduction of 
vaccination it was estimated in 2014 worldwide that 9.6 million people have fallen ill with 
TB. Nevertheless, vaccination against TB reduced TB prevalence by 42% in 2015 compared 
to that in 1990 [1].
World Health Organization (WHO) controls BCG vaccine, and the WHO Expert Committee 
on Biological Standardization (ECBS) has developed the international requirements for 
the manufacture and control of BCG vaccine. In 2009, for BCG vaccines of three different 
sub-strains (Danish1331, Tokyo 172-1 and Russian BCG-I), WHO Reference Reagents were 
established by WHO ECBS. In addition, quality control requirements comprising molecular 
genetic characterization of final lots and working seeds of BCG vaccines were suggested [2]. 
Russian research laboratories performed whole genome sequencing (WGS) of BCG Russia 
sub-strain genome as WHO and good manufacturing practice (GMP) recommended [3–5]. 
Currently, ten whole genome sequences of BCG sub-strains including BCG Russia are avail-
able in GenBank. It should be noted that since the 1920s, cultivation of the original strain 
BCG resulted in the emergence of numerous sub-strains that have evolved from it. So, now 
we could investigate the evolution of BCG sub-strains and the endpoints of this evolution 
could be assessed likewise in the study of Darwinian biological species evolution [6]. The 
reason for BCG sub-strains’ transition remains unclear because the progenitor of BCG strains 
was lost. The comparative analyses of genome features of different BCG sub-strains can help 
in solving this problem.
The attention was focused on mobile elements of BCG sub-strain genomes especially on pro-
phage sequences because of their contribution to the bacterial genome patterning. Following 
Brüssow et al. [7], 12 years later, we can reaffirm that there is a renaissance of phage research 
because now we have a lot of information about bacterial and phage genomes in the inter-
national databases. It was noticed that reintroduction of the fitness factor by phages usually 
influences the pathogenic factors of bacteria cells [8]. Thus, phages are of great importance 
for bacterial short-term adaptation and our goal was to estimate a potential contribution of 
prophage sequences on the mosaic structure of vaccine BCG sub-strain formation.
2. BCG genome sequencing
M. bovis AF2122/97 (Accession Number NC_002945) was the first M. bovis strain, where com-
plete genomic sequence was determined [9]. The first BCG genomic sequence was performed 
for BCG Pasteur 1173P2 (NC_008769.1) [10]. The sequences of these strains such as Tokyo 
172 (NC_012207.1) and Moreau RDJ (NZ_AM412059.1) were generated from the small-insert 
libraries (1–4 kb) by using BigDye terminator chemistry on ABI377- or ABI3700-automated 
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DNA sequencers [9–12]. The large-insert library (40 bp) preparation method was used for Mexico 
BCG sub-strain (NC_016804.1) sequencing [13]. Orduña et al. [13] were first who used for BCG 
genome analysis – the next generation sequencing (NGS) based on 454 technology and Sanger 
method. Late shotgun DNA libraries for strain sequencing were performed by commercial 
NGS kits. The strains were sequenced by the combination of 454 and Illumina platforms and 
the Sanger method, for example, BCG 3281 (NZ_CP008744.1) isolated from the human patient 
with TB and Korea 1168P (NC_020245.2) [14]. Single-molecule real-time sequencing (SMRT) 
based on PacBio Systems was allowed to directly sequence DNA and achieve long sequenc-
ing reads (>10,000 bp) with uniform coverage [15]. SMRT in combination with Illumina was 
used for M. bovis 1595 (NZ_CP012095.1) complete genomic sequence determination [16]. The 
further development of SMRT technology was allowed to use this platform alone for complete 
genomic sequencing. Sequences of BCG sub-strain 26/ATCC 35735/Montreal (CP010331.1) and 
M. bovis 30 (CP010332.1) could be considered as the example of this approach [17]. Whole 
genome sequence of BCG Russia sub-strain was performed using 454 and Sanger technology 
for short-gun and paired-end libraries. Whole genome map (WGM) creation was useful for the 
control of the repeat regions.
3. Comparative genome analyses as proof of BCG Russia genome 
stability
In the vaccine manufacture, one of the important features of BCG sub-strain is the genome stabil-
ity. So, BCG vaccines’ quality control and production now include characterization of BCG sub-
strain genome. The importance of molecular genetic characterization is confirmed by the WHO 
requirements. According to these requirements, WGS of the last seed lot of BCG Russia (BCG 
Russia 368, 2006 year) was performed. Besides, two BCG Russia sub-strains from seed lots of 
1963 and 1982 years (BCG Russia 311 and BCG Russia 977) were analyzed on the basis of WGS.
Comparative analyses of three BCG Russia sub-strains from different seed lots revealed only 
two differences. The first difference was the single-nucleotide polymorphism (SNP) in the posi-
tion 3,175,301 (numeration according to reference strain BCG Tokyo) in the sub-strain BCG 
Russia 368. This SNP leads to the synonymous mutation in the uridylyltransferase gene. In 
the generation of 1963 and 1982, this mutation was not registered.
The second change in genome-affected glycerol-3-phosphate acyltransferase gene is shown 
in Figure 1. The mutation that occurred in this gene in the position 2,744,580 (an insertion 
of TGT bases instead of C base) truncated the protein. Nevertheless, the mutation was not 
concerned with the conservative domain of glycerol-3-phosphate acyltransferase and the pro-
tein could be functional. It should be noted that not all reads had the insertion of TGT. The 
changes were registered only for 14% reads of BCG Russia 311 and 54% reads of BCG Russia 
977. In the last BCG Russia 368 generation, this mutation wasn’t found. So, the genome struc-
tures of three different BCG Russia seed lots remain stable. The last BCG Russia 368 genera-
tion that is discussed in the text later was deposited in GenBank with the Accession Number 
NZ_CP009243.1.
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4. In silico genotyping of BCG-Russia sub-strain
Genomic feature of BCG Russia, as well as all BCG sub-strains, is a large deletion of the 10-kb 
genomic region of difference 1 (RD1) [18].
Spoligotyping profile is the second known characteristic of BCG sub-strain. This method is 
based on detection of Direct Repeats (DR) on the right and left sides of IS6110. DR loci are 
members of a universal family of sequences, designated as clustered regularly interspaced 
short palindromic repeats (CRISPR) sequence family.
Spoligotype profile of BCG Russia was typical for M. bovis with the absence of spacers 3, 9, 16, 
and 39–43, the in silico pattern corresponded to spoligo-international-type number (SIT) 482 
according to the SPOLDB4 Database [19, 20].
The Mycobacterial interspersed repetitive unit (MIRU) profile of BCG Russia sub-strain based 
on 12 MIRU loci was 232,324,253,222 according to in silico genome analysis.
The whole data of BCG Russia MIRU-variable-number tandem repeats (VNTR) loci are sum-
marized in Table 1. The repeat unit size (bp) and repeat number are indicated in the brackets, 
Figure 1. Comparison of different glycerol-3-phosphate acyltransferase variants in the three generations of BCG Russia. 
(A) Alignment of whole and truncated variants of glycerol-3-phosphate acyltransferase. (B) Fragment of glycerol-3-
phosphate acyltransferase with mutation. Hash-amino acids residues in conservative domain of glycerol-3-phosphate 
acyltransferase important for the enzymatic activity.
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partial repeat size (bp) is outside. One discrepancy in polymerase chain reaction (PCR) and 
in silico results was revealed. The number of repeat units in MIRU_4/ETR_D was three in 
accordance with MIRU-VNTR analysis of BCG Russia genome data obtained in three dif-
ferent laboratories (NZ_CP009243.1, CP011455.1, CP013741.1). The number of repeat units 
in MIRU_4/ETR_D of BCG Tokyo was identical. However, PCR analyzes of MIRU-VNTR 
performed by Supply et al. [21] for BCG Russia sub-strain and by Mokrousov et al. [22] for the 
strains isolated from BCGitis patients revealed only two repeat units in MIRU_4/ETR_D. The 
discrepancy in PCR and in silico analyses of MIRU-VNTR could be explained by difficulties 
in the amplification of high GC genomes. The similar discrepancy in PCR and in silico results 
was described by Iwamoto et al. [23] for M. tuberculosis H37Rv. The repeat number in Mtub39 
locus was five in PCR analysis but two copies were revealed in in silico genome investigation.
5. Is the original BCG Russia sub-strain recA a mutant?
High degree of genomic stability of BCG Russia sub-strain is seen as an inexplicable fact by 
some scientists. One of the explanations of this fact proposed by Keller et al. is in the highly 
cited paper [24]. They postulated recA gene inactivation in BCG Russia sub-strain. RecA is a 
multifunctional and ubiquitous recombinase protein involved both in general recombina-
tion and in DNA repair. RecA-dependent recombination mediates genetic rearrangements 
Locus Copy number of locus, bp* Locus Copy number of locus, bp
MIRU_2 (53 × 2) + 8 MIRU_23 (53 × 4) + 5
Mtub04 (51 × 0) + 30 MIRU_24 (54 × 2) + 30
ETR_C (58 × 4) + 37 MIRU_26 (51 × 5) + 13
MIRU_4/ETR_D (77 × 3) + 4 MIRU_27/QUB-5 (53 × 3) + 25
MIRU_40 (54 × 2) + 19 Mtub34 (54 × 2) + 51
MIRU_10 (53 × 1) + 51 MIRU_31/ETR_E (53 × 2) + 3
MIRU_16 (53 × 3) + 18 Mtub39 (58 × 2)
Mtub21 (57 × 0) + 34 QUB-26 (111 × 4) + 24
MIRU_20 (77 × 2) + 11 QUB-4156 (32 + (59 × 0) + 19)
QUB-11b (69 × 3) + 10 MIRU_39 (53 × 1) + 29
ETR_A (75 × 5) + 20 QUB-3232 (56 × 5) + 48
Mtub29 (13 + (57 × 1) + 35) VNTR-3820 (59 × 5) + 47
Mtub30 (58 × 1) + 53 VNTR-4120 (57 × 2) + 23
ETR_B (57 × 5) + 8
*(Repeat unit size (bp) × Repeat number) + Partial repeat size (bp).
Table 1. The copy number of MIRU-VNTR loci in BCG Russia genome.
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resulting in increased genetic instability, while RecA-mediated DNA repair mechanisms 
have been shown to be essential for intracellular survival and persistence [25].
Among the mechanisms of bacterial evolution, the leading role belongs to recombination 
events. The large-scale rearrangements, deletions and duplications were revealed during 
comparative genomics analyses in M. leprae [26], M. tuberculosis [27] and M. bovis BCG [10]. 
Gene duplication has led to the origin of the half tubercle bacillus proteins [28]. Tandem dupli-
cations and homologous recombination also make a significant contribution to the diversity 
of mycobacteria. As an example, recombination between adjacent repeats of IS6110 elements 
resulted in deletions of several genome regions in M. tuberculosis H37Rv [27], https//www.
ncbi.nlm.nih.gov/pmc/articles/PMC2483709/ - B33 [29].
Keller et al. detected the single-nucleotide insertion of “C” at the 5′ end of the recA gene of 
BCG Russia sub-strain received from TD Allergen [24]. As a result, the stop codon was formed 
and recombinase A synthesis was absent. These data have not been confirmed by the genome 
analysis of the original BCG Russia sub-strain. Whole genome sequence (NZ_CP009243), 
obtained in our laboratory, and other sequences (CP011455.1, CP013741.1), did not have the 
single nucleotide insertion in the recA gene. So the complete reading frame for recombinase A 
was annotated. Thus, the original BCG Russia sub-strain is not a recA mutant and the stability 
of the BCG Russia genome cannot be associated with recA inactivation.
Keller et al. findings may indicate that the sub-strain used by authors was not original or has 
been changed during cultivation. The last one is possible. According to our data whole and 
truncated variants of glycerol-3-phosphate acyltransferase gene was identified in one of the 
BCG Russia generations (Figure 1).
6. The “early” sub-strain genomes comparison
Genome sequences were compared using BCG sub-strain Tokyo 172 genome, a member of 
the “early” sub-strains group as reference. First, among this group, BCG Tokyo sub-strain is 
closest to BCG Russia sub-strain as regards the time of its provision by the Pasteur Institute 
to Tokyo (in 1925). Second, it was lyophilized in the 1940s and used later as a freeze-dried 
vaccine, as BCG Russia sub-strain. Then, in 1960, the 172nd transfer on bile-potato medium 
was freeze dried and adopted as a primary seed lot [30]. Finally, one of the first BCG genomes 
that were accurately sequenced, assembled, and submitted to GenBank was the genome of 
this seed lot [11].
We observed no significant diversity in the sequences of the BCG Russia 368 and BCG Tokyo 
172 genomes. The revealed genomic differences were summarized in Table 2 and could be sub-
divided into three groups: region of differences (RDs), ins/del and SNP. Only two RDs were 
detected between the “early” sub-strains. First, a 22 bp insertion was found in the TetR family 
transcriptional regulator gene of BCG Russia 368 genome. One variant of Japan BCG vaccine 
(Type I), submitted in GenBank, included this deletion (RD16). The RD16 band identical to those 
of other BCG sub-strains was found in the Type II strain [31]. A 1602 bp deletion in BCG Russia 
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368 genome was the second RD, corresponding to the region from 4,110,452 to 4,112,053 bp in 
BCG Tokyo 172, beginning in JTY_RS19265 (ribonuclease gene), including JTY_RS19270 (anti-
toxin VapB48 gene) and finishing inside JTY_RS19275 (glutamate-cysteine ligase gene).
The sub-strains used for vaccine production in Bulgaria (BCG Sofia) and India were obtained 
from BCG Russia. Nowadays, UNICEF uses four variants of BCG vaccine on behalf of the Global 
Alliance for Vaccines and immunization. The Statens Serum Institute in Denmark produces 
BCG-Denmark; Bulbio (BBNCIPD) in Bulgaria; and the Serum Institute in India produces BCG-
Russia (genetically identical to BCG-Bulgaria) and the Japan BCG laboratory produces BCG-
Japan [32].
We could trace the genome characteristics of BCG Russia daughter sub-strains using pub-
lished data. Stefanova et al. analyzed the BCG sub-strain used for production in Bulgaria 
(named Sofia SL222) with M. tuberculosis microarrays. They detected a 1.6-kb deletion that 
affects Rv3697c and Rv3698 homologs. The deletion of this region was also noted in BCG 
Russia but not in any other strains [33]. The authors concluded that RD 1602 bp is an old 
deletion, because BCG Pasteur was replaced with BCG Russia in Bulgaria BCG laboratory in 
the 1950s.
According to Seki M. et al. differences between the “early” sub-strain Tokyo and the “late” 
sub-strain Pasteur were more significant and the number of RD increased tenfold [11].
Less ins/del differences were found between BCG Russia and BCG Tokyo genomes, then 
between BCG Tokyo and BCG Pasteur genomes. The size of ins/del differences was small: 
only 1–9 bp.
However, the number of SNPs was nearly the same in the two pairs of the genomes. Non-
synonymous SNP in BCG Russia 368 amounted to 60%, but most of them were associated 
with conservative substitutions in the proteins. Only seven proteins had radical substitutions, 
though three of them were from the PE-PGRS/PPE family. This finding has emphasized the 
significance of these proteins for BCG sub-strain adaptation.
Type of differences Number of differences
BCG Russia368/BCG Tokyo 
172
BCG Tokyo 172/BCGPasteur1173P2 [11]
Region of Differences (more than 20 bp) 2 20
Insertions/deletions <20 bp (1–9 bp) 10 20
SNP in total 52 68
intergenic SNP 11
synonymous SNP 8
nonsynonymous SNP (without nonsense) 31
Nonsense SNP as variant of nonsynonymous 2
Table 2. Genomic differences of BCG Russia 368, Tokyo 172, and Pasteur 1173P2 sub-strains.
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Figure 2. The circular restriction map of BCG Russia 368 whole genome. The restriction map was obtained by DNA 
digestion with NheI.
7. A whole genome restriction map analysis
The large array of published literature accentuated the important role of RD in BCG sub-
strains differentiation. For checking these statements the methods by OpGen Incorporated 
Company was used. So, first of all, the assembly of DU2 region and the number of tandem 
duplications in this region in BCG Russia 368 genome were performed by the Argus™ Optical 
Mapping System. WGM of the sub-strain BCG Russia 368 was created by the laboratory 
of OpGen Incorporated Company (Maryland, the USA), according to the Argus™ Optical 
Mapping System user manual [34]. DNA was digested with NheI. Map Solver software ver-
sion 3.2 was employed for creating the final circular WGM; the whole genome map of BCG 
Russia 368 is represented in Figure 2. The separate comparison of DU2 regions (Figure 3) has 
shown that genomes BCG Russia 368 and BCG Tokyo 172 are identical in this region, unlike 
from the BCG Pasteur optical map, which can be confirmed by presence of three copies (triple 
tandem duplications) in the DU2 region of BCG Russia 368.
The cluster construction based on map similarity of the six references of BCG sub-strains is 
shown in Figure 4. As you can see, the cluster was split into two groups: BCG Tice (ATCC 
35743) was attributed to the group of the “early”, while BCG Mexico to the “late” group of 
sub-strains in accordance with the NheI restriction fragments.
Mycobacterium - Research and Development218
8. Genome map construction and the analyses of repetitive elements 
of BCG Russia 368
The whole genome gap-less BCG Russia 368 chromosome after the verification of the number 
of DU2 repeats was visualized in GeneWiz [35] (Figure 5). Genome atlas option of GeneWiz 
primarily GC Skew was selected as an appropriate instrument for verifying the accuracy of 
Figure 3. Aligned OpGen maps for BCG Russia 368 and reference BCG sub-strains created for DU2 region. (1) OpGen 
map created in silico for BCG Russia 368 genome fragment. (2) OpGen map of BCG Russia 368 whole genome digestion 
with NheI in vitro. (3 and 4) OpGen map created in silico for BCG Tokyo 172 and BCG Pasteur 1173P2 genome fragments. 
All OpGen maps were created by DNA digestion with NheI. Vertical lines are pointed out at restriction sites. Tree copies 
of the DU2 region in BCG Russia 368 and BCG Tokyo 172 genomes are marked as green, blue and purple bars. The 
genome region from the astB to the sdhD genes (DU2 region) is represented as the green bar. The astB gene in the second 
and the third copies of DU2 region (blue and purple bars) was truncated.
Figure 4. Map similarity cluster reconstruction for seven BCG sub-strain. The optical restriction maps of BCG Russia 
368 and six reference BCG sub-strains obtained in silico were used for map similarity cluster reconstruction. The cluster 
construction was carried out using UPGMA (unweighted pair-group method using arithmetic averages) algorithm in 
OpGen MapSolver v.3.2.0. Program.
Mosaic Structure as the Main Feature of Mycobacterium bovis BCG Genomes
http://dx.doi.org/10.5772/intechopen.75005
219
Figure 5. M. bovis BCG Russia 368 genome map.
genome assemblies and OriC detection. The place of the change in GC Skew agreed with the 
OriC and the first nucleotide position in the BCG Russia 368 genome. Other DNA properties, 
intrinsic curvature, stacking energy, position preference, global direct repeats, global inverted 
repeats, and AT-content, were essential for genome structure description.
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Different types of repeats visualized by GeneWiz and shown in Figure 5 correlated with the 
specific genome elements identified with the specific resources (Table 3).
Name Number
REP 6
CRISPR 5
Prophage 2
PPE protein gene 66
PE protein gene 33
PE_PGRS protein gene 69
IS elements 41
Table 3. Specific genome elements in BCG Russia genome.
Figure 6. Localization of mobile elements (IS, repeats, prophage sequences), PE, PPE, and PE_PGRS genes in BCG Russia 
368 genome. The circular map of BCG Russia 368 genome was visualized by the GenomeVx program. All of the prophage 
sequences were predicted by PHAST. Description of scheme: Repeats (REP, VNTR, and CRISPR elements) – circle A; 
phage sequences (according to PHAST) – B; IS elements – C; genes for PE, PPE, and PE_PGRS proteins – D. Accepted 
abbreviations: REP – Repetitive extragenic palindrome element; CR – CRISPR or possible CRISPR sequences predicted 
by CRISPRfinder; VNTR – Variable number tandem repeat; IS – Insertion sequence elements. Phages sequences: TI – 
BCG tice (CP003494.1); MN – BCG Montreal (CP010331.1); AF – M. bovis AF2122/97 (BX248333.1); PHR-2-rep – (922 bp 
repeat of 7.5 kb), PHR-1 – (11 kb), and PHR-2 – (7.5 kb) of BCG Russia. In the color code-ciphered phage sequences 
discovered in different M. bovis genomes: BCG tice (CP003494.1) – purple; BCG Montreal (CP010331.1) – blue; M. bovis 
AF2122/97 (BX248333.1) – orange; BCG Russia 368 (CP009243) – red.
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The insertion sequences (IS) elements and affiliated resolvases, transposases, and integrases 
genes were predicted by ISfinder. Classification of IS elements and determination of inverted 
repeats flanking IS were made by the use of ISfinder database [36, 37]. Clustered regularly 
interspaced short palindromic repeats (CRISPR) and RISPR-associated Cas and Csm family 
proteins were predicted by CRISPRfinder [38, 39].
Locations of IS elements, repeats, prophage sequences, and PE, PPE, and PE_PGRS genes in 
BCG Russia 368 genome are visualized in Figure 6. Most of the repetitive elements of BCG 
Russia 368 genome, including some prophage sequences, are coinciding, overlapping, or 
interconnecting. So, it is hard to annotate some fragments of BCG Russia 368 genome. Special 
difficulties have arisen in the differentiation of bacterial and phage genes during PE/PGRS 
genes characterization.
9. The phages predicted in M. bovis genomes
Along with other mobile elements, the variability of predicted prophages may be the best 
indexes for characterization of mosaic structure genome. All of the prophages described in M. 
bovis genome were computed us by PHAge Search Tool (PHAST) [40, 41]. GenVision Plug-In 
of the DNASTAR Lasergene program package was selected for the visualization of prophage 
sequences. According to PHAST data, all of the predicted phages could be shared into three 
groups (see Figure 7). So, the first group composed of the common ones for M. bovis and M. bovis 
BCG prophages. A 7.5-kb prophage was revealed in most of the BCG genomes and in three M. 
bovis; exceptions include– BCG sub-strains Tice and Montreal. A 20.3-kb prophage in “early” 
sub-strain genomes (BCG Tokyo, Moreau, Russia) was replaced by an 11.2-kb one but was lost 
in “late” sub-strain genomes. The second group represented six BCG Montreal prophages, the 
third represented 15 BCG Tice sub-strain prophages. The prophages in the second and third 
groups were unique and did not coincide with the prophages of other sub-strains (see circle B in 
Figure 6). Like most of phage ORFs in the common ones, M. bovis prophages were annotated as 
genes belonging to the order Caudovirales (Myoviridae, Siphoviridae, and Podoviridae family), 
while most of phage ORF in BCG Tice or BCG Montreal prophages were similar to the genes of 
various Herpesviruses (Human, Bovine, Macaci, Alcela, Anguil).
The mosaic BCG genome structure has been verified by comparative prophage analyses. A par-
tial similarity of BCG Tice/BCG Montreal prophage fragments has been identified after pair-wise 
alignment of BCG Montreal and BCG Tice phage sequences with BCG Russia 368 whole genome. 
The regions of similarity defined as the purple (BCG Tice) and blue (BCG Montreal) blocks on 
circle B are phage sequences discovered in different M. bovis genomes (Figure 6). In BCG Russia 
368 genome, Tice-specific prophages (13.4 and 13.9 kb) were split into five and three parts, respec-
tively. Fragments which are homologous to BCG Montreal-specific prophages represented in the 
genome of BCG Russia 368 as a sequence with multiple gaps ranging from 14 to 128 bp.
In turn, the 7.5-kb BCG Russia 368 prophage was split on 0.9- and 6.6-kb fragments located 
in different regions of BCG Tice/Montreal genomes. Moreover, these fragments lacked the 
transposase gene, which was specific to 7.5-kb BCG Russia 368 prophage.
Mycobacterium - Research and Development222
Also, the 7.5-kb BCG Russia 368 prophages had 922-bp repeats in BCG Russia 368 genome 
(red bar in Figure 6, circle B) and was located near ISMt1 insertion element. Interestingly, 
besides prophage fragments, two intact prophages associated with the insertion elements 
have been predicted by PHAST in BCG Russia 368 genome. Thus, 11-kb and 7.5-kb pro-
phage sequences were linked with IS6110 and IS1560 elements, respectively. So, the connec-
tion between prophage sequences and the IS elements has a considerable impact on the BCG 
genome evolution.
10. Phylogeny reconstruction
Phylogeny reconstruction was made using the genome sequences of analyzed M. bovis 
strains and BCG sub-strains. The full-genome comparison and phylogeny reconstruc-
tion were based on BLAST alignment and neighbor-joining algorithm [42] used in NCBI 
BLAST. The trees were represented by MEGA 6.0 [43]. Taking into account the prophage 
profile data, the congruence of obtained phylogenetic tree and vaccine sub-strains geneal-
ogy based on the DU2 region [10, 44] has been evaluated. M. bovis strains and BCG sub-
strains formed different clusters on the tree (see Figure 8). As was expected, the “early” 
(Russia, Tokyo) and the “late” (Pasteur 1173P2, Korea 1168P, Mexico) BCG sub-strains 
formed separate but closely related groups. The basal branch in the BCG cluster was rep-
resented by BCG Moreau sub-strain. The unexpected position of the BCG Tice and the 
BCG Montreal has been revealed. The BCG Montreal showed some relationship with the 
“early” sub-strains. The BCG Tice has been placed in the most divergent basal position on 
the tree. In turn, BCG 3281, isolated from a pulmonary TB, patient had the relationship 
Figure 7. Comparative analyses of phage types from BCG Russia 368 and references M. bovis genomes. Color arrows 
indicate the location of phage genes. (a) Phages common for all analyzed genomes: 7.5, 11.0, and 20.3 kb – In all the 
analyzed strains (accession NZ_CP009243.1, NC_012207.1, NC_008769.1, NZ_CP003494.1, CP010331.1, NC_016804.1, 
NC_002945.3, NZ_AM412059.1, NZ_CP008744.1, NZ_CP012095.1, CP010332.1, NC_020245.2); (b) phages specific for 
BCG tice: 13.4, 14.0 18.6, 22.7, 28.4, and 30.7 kb; (c) phages specific for BCG Montreal: 6.9, 7.1, 7.2, 7.3, 8.8, 9.3, 9.5, 9.9, 10.1 
10.5, 11.5, 12.4, 13.0, 13.4, and 13.9 kb.
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Figure 8. Whole genome phylogeny of M. bovis strains. Colored blocks describe the DU2 region type in BCG sub-strains: 
blue – DU2-I, yellow – DU2-III, red – DU2-IV. Unpainted blocks with colored borders and numbers inside define types 
of prophage profiles and prophage size in kb. Red borders with asterisks indicate the number of unique prophages 
identified in BCG tice and BCG Montreal genomes.
with the “late” sub-strains. Remarkably, all phylogenetic groups of the tree were charac-
terized by specific sets of prophage sequences. The DU2 region genealogy only partially 
correlated with the whole genome phylogeny obtained in this study. If the DU2-I “early” 
sub-strain group showed common origin but the DU2-IV group split apart (see Figure 8). 
The BCG 3281 that represented DU2-III group [45] took an intermediate position. One of the 
possible explanations for this discrepancy may be numerous prophage-associated genome 
rearrangements.
11. Discussion
Numerous comparative genomics investigations of BCG sub-strains confirmed significant 
genomic polymorphism of BCG sub-strains which arose from one progenitor. RDs, indels 
and SNPs are real evidences still going on in the in vitro evolution of BCG sub-strains.
Here we supposed that genomic evolution and the BCG sub-strains diversity is a direct 
consequence of prophage-associated genome rearrangements. It is well known that 10–20% 
of bacterial genomes represented prophage sequences. Most of the prophages are damaged 
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and mutated. Nevertheless, recombinant events between homologous prophage sequences 
are possible. Moreover, some genes of defective prophages can be still working [46]. So, 
prophage genome content is an important biological driver/trigger of genomic rearrange-
ments and evolution. Extensive contribution of prophages to bacterial fitness was supposed 
as a result of unexpected evolutionary prophage patterns [47]. Suggesting our assump-
tion, outstanding differences between prophage profiles have been revealed in our com-
parative genome analysis of nine BCG sub-strains and three M. bovis strains. Big differences 
in the number and composition of prophages in the genomes of the late strains Tice and 
Montreal were discovered. According to the Brosch et al., both BCG Tice and BCG Montreal 
or Frappier were taken from the Pasteur Institute after 1934. They had close phylogenetic 
relations because they fall in one phylogenetic group, “DU2 IV, Δint” [10]. Dr. Rosenthal, 
who received the first Tice sub-strain from the Pasteur Institute, demonstrated heterogene-
ity of the “late” BCG sub-strain. It was a progenitor of at least six different daughter BCG 
sub-strains: H, K, E, L, LH, and BL. The sub-strain BL was strongly attenuated in laboratory 
studies. In 1952, BL was mixed with a new routine ‘P’ strain, received from the Pasteur 
Institute in 1951, in the ratio 3:1. This new sub-strain was called BLP. Since 1953 only 
freeze-dried BCG vaccine from this mixed strain has been produced [30]. The history of 
BCG Montreal sub-strain is also well known. Three times these BCG sub-strains were sent 
to Canada from the Pasteur Institute [30]. Significant changes of BCG genomes have been 
reflected in the appearance of new prophage profiles in BCG Tice and BCG Montreal sub-
strains. It could also impact on vaccine properties of the sub-strains. According to Zhang 
et al. [48], BCG Tice, BCG Montreal/Frappier along with BCG Prague, and BCG Phipps 
sub-strains have lost the largest number of T-cell epitopes, defining its vaccine properties. 
In contrast, BCG Russia and BCG Tokyo sub-strains still have the largest number of T-cell 
epitopes among other BCGs. So an extended genomic sequencing is very important to iden-
tify prophages as potential markers of genomic rearrangement. Prophage studies could 
enhance our understanding of the genetic features of various BCG sub-strains and may also 
be useful for checking the genetic stability of the seed-lot sub-strain.
12. Conclusions
People migration from regions with a high incidence of TB and the growth of the number 
of HIV-infected individuals last decade resulted in the necessity of TB vaccination not only 
among children but also among adolescents and adults. In 2015, 15 vaccine candidates were 
considered in clinical trials. BCG vaccine replacement or vaccine boosting for the protection 
of adolescents and adults were considered. Recombinant BCGs, recombinant viral-vectored 
platforms, protein/adjuvant combinations, attenuated M. tuberculosis strains and mycobac-
terial extracts were included in the list [1]. A subunit vaccine developed in N.F. Gamaleya 
Research Center was based on the fusion of mycobacterial proteins with cellulose-binding 
domain [49]. On the other hand, new areas of BCG vaccine application have been proposed. 
As most humans are born in bacteriological environments characterized by a low microbial 
diversity, the effects of BCG vaccine administrated immediately after birth, as a modulator 
of Th-1/Th-2 responses, is very important and should be analyzed [50]. In this situation, the 
control of BCG genome stability is the important task, which will continue to be relevant.
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